Verastem Inc 's ability to collect accounts receivable sequentially worsen to 6.42, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Verastem Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 57 days, from 51 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 329 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1673 to 2779.

What is Receivable Turnover Ratio?
What is Verastem Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VSTM Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	1290.85 %	-	-	-	-79.24 %
Y / Y Revenue Change	1775.43 %	-	-	-	-78.63 %
Receivable Turnover Ratio (TTM)	6.42	7.14	7.02	6.09	4.12
VSTM's Total Ranking	# 2779	# 1673	# 0	# 0	# 0
Accounts Receivable average collection period days	57	51	52	60	89
Seq. Receivable Change	184.25 %	15.26 %	31.22 %	223.51 %	-
Seq. Revenue Change	114.65 %	6.48 %	55.98 %	426.06 %	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 90
Healthcare Sector	# 330
Overall Market	# 2779

Receivable Turnover Ratio Statistics
High	Average	Low
0.51	0.22	0.02
(Jun 30 2021)		(Sep 30 2021)

VSTM Company Profile • Back to VSTM Efficiency Comparisons • Compare VSTM Receivables Turnover Ratio to its Competitors

Financial Statements
Verastem Inc 's Accounts Receivable	$ 29 Millions	Visit VSTM's Balance sheet
Verastem Inc 's Sales TTM	$ 88 Millions	Visit VSTM's Income Statement
Sources of VSTM's Revenues		Visit VSTM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VSTM's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VSTM's Growth Rates	VSTM's Roa	VSTM's Inventory Turnover Ratio	VSTM's Dividend Comparisons
VSTM's Profitability Ratios	VSTM's Roi	VSTM's Asset Turnover Ratio	VSTM's Dividend Growth
VSTM's Valuation Ratios	VSTM's Roe	VSTM's Financial Strength Ratios	VSTM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Alpha Teknova Inc	8.33	$ 43.407 Millions	$ 5.208 Millions
Rockwell Medical inc	8.31	$ 69.827 Millions	$ 8.400 Millions
Inspire Medical Systems inc	8.25	$ 899.227 Millions	$ 109.027 Millions
Sonoma Pharmaceuticals Inc	8.24	$ 21.920 Millions	$ 2.661 Millions
Madrigal Pharmaceuticals Inc	8.19	$ 1,283.940 Millions	$ 156.857 Millions
X4 Pharmaceuticals Inc	8.17	$ 9.441 Millions	$ 1.156 Millions
Seastar Medical Holding Corp	8.11	$ 1.713 Millions	$ 0.211 Millions
Atricure Inc	8.08	$ 567.747 Millions	$ 70.232 Millions
Concentra Group Holdings Parent Inc	8.07	$ 2,287.465 Millions	$ 283.300 Millions
Penumbra Inc	8.06	$ 1,504.874 Millions	$ 186.788 Millions
Sanuwave Health Inc	8.04	$ 43.903 Millions	$ 5.461 Millions
Sight Sciences Inc	8.04	$ 83.351 Millions	$ 10.368 Millions
Aveanna Healthcare Holdings Inc	8.03	$ 2,602.820 Millions	$ 324.026 Millions
Avita Medical Inc	7.99	$ 75.631 Millions	$ 9.463 Millions
Koru Medical Systems Inc	7.97	$ 45.108 Millions	$ 5.658 Millions
Alphatec Holdings Inc	7.94	$ 814.780 Millions	$ 102.662 Millions
Safe Pro Group Inc	7.94	$ 2.881 Millions	$ 0.363 Millions
Henry Schein Inc	7.91	$ 13,602.000 Millions	$ 1,719.000 Millions
Tela Bio Inc	7.86	$ 80.535 Millions	$ 10.243 Millions
Exelixis Inc	7.81	$ 2,435.920 Millions	$ 311.950 Millions
Castle Biosciences Inc	7.79	$ 357.278 Millions	$ 45.867 Millions
Trisalus Life Sciences Inc	7.78	$ 45.179 Millions	$ 5.808 Millions
Idexx Laboratories Inc	7.75	$ 4,553.792 Millions	$ 587.472 Millions
Vycor Medical Inc	7.68	$ 1.807 Millions	$ 0.235 Millions
Aurinia Pharmaceuticals Inc	7.67	$ 311.507 Millions	$ 40.624 Millions
Beta Bionics Inc	7.65	$ 119.513 Millions	$ 15.615 Millions
Lemaitre Vascular Inc	7.65	$ 262.923 Millions	$ 34.370 Millions
Novocure Limited	7.62	$ 699.193 Millions	$ 91.768 Millions
Natera Inc	7.61	$ 2,707.077 Millions	$ 355.618 Millions
Co diagnostics Inc	7.58	$ 0.721 Millions	$ 0.095 Millions

Date modified: 2026-09-26T07:14:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.